OSI Systems Inc. (OSIS) Company Profile
OSI Systems, Inc., together with its subsidiaries, designs and manufactures electronic systems and components for homeland security, healthcare, defense, and aerospace markets worldwide. The company operates in three divisions: Security, Healthcare, and Optoelectronics and Manufacturing. The Security division provides security and inspection systems under the Rapiscan Systems name. Its products include baggage and parcel inspection, cargo and vehicle inspection, hold baggage screening, and people screening products to search for weapons, explosives, drugs, and other contraband, as well as for the verification of cargo manifests for monitoring the export and import of controlled materials. This division also offers various turn-key security screening solutions under the S2 trade name. The Healthcare division provides patient monitoring, diagnostic cardiology, and anesthesia delivery and ventilation systems under the Spacelabs name that are used in critical care, emergency, and perioperative areas within hospitals, as well as physician?s offices, medical clinics, and ambulatory surgery centers. The Optoelectronics and Manufacturing division offers optoelectronic devices for the aerospace and defense, avionics, medical imaging and diagnostic, renewable energy, biochemistry analysis, pharmaceutical, nanotechnology, telecommunications, construction, and homeland security markets under the OSI Optoelectronics name; and electronics manufacturing services to original equipment manufacturers under the OSI Electronics name. This division also provides laser-based remote sensing devices to detect and classify vehicles in toll and traffic management systems under the OSI Laserscan name; blood pressure cuffs and unifusors under the Statcorp Medical name; and solid-state laser products for aerospace, defense, telecommunication, and medical applications under the OSI LaserDiode trade name. The company was founded in 1987 and is headquartered in Hawthorne, California.
News about OSIS
BioMarin Pharmaceutical (BMRN) Rating Increased to C- at TheStreet
From:www.tickerreport.com
BioMarin Pharmaceutical (NASDAQ:BMRN) was upgraded by stock analysts at TheStreet from a “d+” rating to a “c-” rating in a report issued on Friday.
Several other analysts also recently issued reports on the company. JPMorgan C...Read More>>>
Zacks: Brokerages Expect Energy Recovery, Inc. (ERII) Will Post Quarterly Sales of $19.85 Million
From:www.tickerreport.com
Equities research analysts predict that Energy Recovery, Inc. (NASDAQ:ERII) will announce sales of $19.85 million for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for Energy Recovery’s earnings. The lowest sales...Read More>>>
$45.32 Million in Sales Expected for Ligand Pharmaceuticals Inc. (LGND) This Quarter
From:www.tickerreport.com
Equities analysts expect Ligand Pharmaceuticals Inc. (NASDAQ:LGND) to post $45.32 million in sales for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for Ligand Pharmaceuticals’ earnings, wi...Read More>>>
Bellerophon Therapeutics (BLPH) Trading 10% Higher Following Insider Buying Activity
From:www.tickerreport.com
Bellerophon Therapeutics Inc (NASDAQ:BLPH) shares traded up 10% during mid-day trading on Monday after an insider bought additional shares in the company. The stock traded as high as $0.91 and last traded at $0.88. 18,690 shares were traded during m...Read More>>>
Constellation Pharmaceuticals: A Recent IPO Of Interest
From:seekingalpha.com
Shares of Constellation Pharmaceuticals (CNST) have fallen by about 30% since the IPO was priced at $15 in July. Interestingly enough, the company had to decrease the size of the offering significantly, raising $60 million instead of the planned $80 ...Read More>>>
